Orwin John A
SEC CIK 1477384 · EDGAR
Most active insiders at TRAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ware J. Anthony | Dir | — | $1.76M |
| 2 | Jain Rita | Dir | — | — |
| 3 | Marquet Magda | Dir | — | — |
| 4 | Schmid John P. | Dir | — | — |
| 5 | Orwin John A | Dir | — | — |
| 6 | ANAPTYSBIO, INC | 10% | — | — |
| 7 | FENTON DENNIS M | Dir | — | — |
| 8 | EcoR1 Capital, LLC | 10% | — | -$65.00M |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-17 16:05 | 2026-09-15 | ANAB | ANAPTYSBIO, INC | Orwin John A | Dir | M - OptEx | $0.00 | +1,300 | 18.0K | +8% | $0 |
| D | 2026-09-17 16:05 | 2026-09-15 | TRAX | First Tracks Biotherapeutics, Inc. | Orwin John A | Dir | M - OptEx | $0.00 | +1,300 | 18.0K | +8% | $0 |
| D | 2026-06-17 16:05 | 2026-06-15 | TRAX | First Tracks Biotherapeutics, Inc. | Orwin John A | Dir | M - OptEx | $0.00 | +6,030 | 16.7K | +57% | $0 |
| D | 2026-06-17 16:05 | 2026-06-15 | ANAB | ANAPTYSBIO, INC | Orwin John A | Dir | M - OptEx | $0.00 | +6,030 | 16.7K | +57% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Travere Therapeutics, Inc. | Orwin John A | Dir | A - Grant | $0.00 | +4,000 | 39.4K | +11% | $0 |
| D | 2025-09-17 | 2025-09-15 | ANAB | ANAPTYSBIO, INC | Orwin John A | Dir | M - OptEx | $0.00 | +1,300 | 10.7K | +14% | $0 |
| D | 2025-06-17 | 2025-06-15 | ANAB | ANAPTYSBIO, INC | Orwin John A | Dir | M - OptEx | $0.00 | +6,030 | 9,365 | +181% | $0 |
| D | 2025-05-16 | 2025-05-15 | TVTX | Travere Therapeutics, Inc. | Orwin John A | Dir | A - Grant | $0.00 | +6,500 | 35.4K | +23% | $0 |
| D | 2024-09-17 | 2024-09-15 | ANAB | ANAPTYSBIO, INC | Orwin John A | Dir | M - OptEx | $0.00 | +1,300 | 3,335 | +64% | $0 |
| D | 2024-06-18 | 2024-06-15 | ANAB | ANAPTYSBIO, INC | Orwin John A | Dir | M - OptEx | $0.00 | +2,035 | 2,035 | New | $0 |
| D | 2024-05-10 | 2024-05-08 | TVTX | Travere Therapeutics, Inc. | Orwin John A | Dir | A - Grant | $0.00 | +6,500 | 28.9K | +29% | $0 |
| D | 2023-05-19 | 2023-05-17 | TVTX | Travere Therapeutics, Inc. | Orwin John A | Dir | A - Grant | $0.00 | +4,500 | 22.4K | +25% | $0 |
| D | 2022-05-12 | 2022-05-11 | TVTX | Travere Therapeutics, Inc. | Orwin John A | Dir | A - Grant | $0.00 | +3,000 | 17.9K | +20% | $0 |
Purchase Sale Sale after option exercise All abbreviations